Newsletter | November 12, 2024

11.12.24 -- CGTs: Avoid This Common Pitfall In Supply Chain Planning

SPONSOR

A Full-Service Solution Partner Disrupting the Outsourcing Paradigm

inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them.

FEATURED EDITORIAL

Cell & Gene Therapies: Avoid This Common Pitfall In Supply Chain Planning

BioPhorum members propose a Design for Supply model for cell and gene therapy supply chain planning. Don't let it take a backseat until the later stages of the product life cycle.

INDUSTRY INSIGHTS

Improving Supply Chain: Accountability, Sustainability, Optimization

Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.

Why You Should Expect More from Your IRT/RTSM

Explore the need for advanced capabilities beyond basic RTSM and the importance of having experienced teams behind IRT solutions to navigate complexities and ensure successful trial execution.

SOLUTIONS

An Early-Phase, Raw-Material, Clinical Manufacturing Case Study

Understanding Options In Direct-To-Patient Clinical Supply